** Shares of drug discovery and intelligent automation solutions provider XtalPi Holdings 2228.HK jump 9.7% to HK$8.17, their highest since Feb. 25
** Stock set for its biggest one-day pct gain since Aug. 6, and on course for a second session of gains
** Co expects first-half revenue to jump nearly five-fold to 500 mln yuan ($69.59 mln) from a year earlier, driven by its collaboration with DoveTree Medicines in relation to the company's provision of drug discovery solutions and services
** Co expects adjusted net profit of not less than 120 mln yuan, compared to an adjusted net loss of 251.4 mln yuan in the year-ago period
** If it makes a profit, this would be the first time for the group to achieve half-year profit
** Hong Kong's healthcare index .HSCIH eases 0.7%, the benchmark Hang Seng Index .HSI slips 0.1%
** YTD, stock up 31.9%
($1 = 7.1851 Chinese yuan)
(Reporting by Donny Kwok)
((donny.kwok@thomsonreuters.com))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.